Dr. John L. Ryan, MD, Ph.D has been the Chief Medical Officer and Executive Vice President of Kadmon Holdings, Inc. (Alternate Name: Kadmon Pharmaceuticals LLC) since 2011. Dr. Ryan has been Vice President of Clinical Development at Genetics Institute LLC since February 1995. Dr. Ryan served as the Chief Medical Officer and Senior Vice President of Cerulean Pharma Inc. from March 10, 2010 to May 2011. Dr. Ryan served as an Acting Chief Medical Officer of Cerulean Pharma Inc. since July 2009 to March 10, 2010. Dr. Ryan served as the Chief Medical Officer of Aveo Pharmaceuticals, Inc. since April 2006. He joined Aveo Pharmaceuticals, Inc. after 11 years at Wyeth where he served as Senior Vice President of Translational Research. He has almost 20 years of experience in drug discovery and development, including expertise in translational medicine and cancer biology. Since 2001, he served as head of the new Department of Experimental Medicine, which was created to explore new technologies such as pharmacogenomics in exploratory clinical trials, to work closely with FDA on clinical pharmacogenomics and to bridge discovery and development with the creation of new biomarkers. Since 1998, he served as Senior Vice President of Clinical Research & Development and assumed leadership of the Oncology and Infectious Disease therapeutic areas as well as the CR&D group. Dr. Ryan served as an Executive Director of Clinical Research at Merck Research Laboratories. Dr. Ryan spent five years at Merck & Co. as Executive Director of Infectious Disease. He serves as a Director of Globavir Biosciences, Inc. He served as the Chairman of the Medical Advisory Board at Cerulean Pharma Inc. since May 2011. He serves as a Member of Scientific Advisory Board at Expression Analysis, Inc. Dr. Ryan served as a Member of Scientific Advisory Board of Arqule Inc. From 1977 to 1989, he served as a Professor in the Department of Internal Medicine at Pennsylvania School of Medicine and Yale University School of Medicine. Dr. Ryan received his Bachelor degree from Yale University. He holds a Ph.D. in Molecular Biophysics from Yale University and an MD from the University of California at San Diego. Dr. John L. Ryan, MD, Ph.D has been the Chief Medical Officer and Executive Vice President of Kadmon Holdings, Inc. (Alternate Name: Kadmon Pharmaceuticals LLC) since 2011. Dr. Ryan has been Vice President of Clinical Development at Genetics Institute LLC since February 1995. Dr. Ryan served as the Chief Medical Officer and Senior Vice President of Cerulean Pharma Inc. from March 10, 2010 to May 2011. Dr. Ryan served as an Acting Chief Medical Officer of Cerulean Pharma Inc. since July 2009 to March 10, 2010. Dr. Ryan served as the Chief Medical Officer of Aveo Pharmaceuticals, Inc. since April 2006. He joined Aveo Pharmaceuticals, Inc. after 11 years at Wyeth where he served as Senior Vice President of Translational Research. He has almost 20 years of experience in drug discovery and development, including expertise in translational medicine and cancer biology. Since 2001, he served as head of the new Department of Experimental Medicine, which was created to explore new technologies such as pharmacogenomics in exploratory clinical trials, to work closely with FDA on clinical pharmacogenomics and to bridge discovery and development with the creation of new biomarkers. Since 1998, he served as Senior Vice President of Clinical Research & Development and assumed leadership of the Oncology and Infectious Disease therapeutic areas as well as the CR&D group. Dr. Ryan served as an Executive Director of Clinical Research at Merck Research Laboratories. Dr. Ryan spent five years at Merck & Co. as Executive Director of Infectious Disease. He serves as a Director of Globavir Biosciences, Inc. He served as the Chairman of the Medical Advisory Board at Cerulean Pharma Inc. since May 2011. He serves as a Member of Scientific Advisory Board at Expression Analysis, Inc. Dr. Ryan served as a Member of Scientific Advisory Board of Arqule Inc. From 1977 to 1989, he served as a Professor in the Department of Internal Medicine at Pennsylvania School of Medicine and Yale University School of Medicine. Dr. Ryan received his Bachelor degree from Yale University. He holds a Ph.D. in Molecular Biophysics from Yale University and an MD from the University of California at San Diego.

Immunobiology [